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Abstract 
The purposes of this study were to determine whether organic cation 
transporters (OCTs) can mediate platinum uptake, and whether OCT 
down-regulation confers resistance against cisplatin (CDDP) in cancer cells. 
Two lung cancer cell lines, PC-6 and PC-14, and their CDDP-resistant 
derivatives, PC-6/CDDP and PC-14/CDDP, were analyzed. OCT expression 
levels were assayed using quantitative RT-PCR and Western blotting. Both 
gene and protein expression of OCT6 were decreased in both CDDP-resistant 
cell lines compared with their expression in their respective parental cells. 
Additionally, the effect of OCT6 overexpression, induced by transfection of 
the OCT6 gene SLC22A16 using a forced expression vector, on intracellular 
platinum accumulation and on cellular sensitivity to CDDP was measured 
using PC-14/CDDP cells. Intracellular accumulation of platinum was 
decreased in PC-14/CDDP cells compared with the parental cells after CDDP 
treatment. Furthermore, OCT6 overexpression induced by transfection of 
the OCT6 gene (SLC22A16) forced expression vector-sensitized PC-14/CDDP 
cells to CDDP and oxaliplatin (L-OHP) concomitant with increased 
intracellular concentration of platinum. These results indicate that OCT6 is 
a mediator of CDDP uptake and that the down-regulation of OCT6 directly 
confers to resistance against CDDP via decreasing the intracellular platinum 
concentration. 
